{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:59:57Z","timestamp":1790225997732,"version":"4.1.0"},"reference-count":127,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AR053483"],"award-info":[{"award-number":["AR053483"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI0822714"],"award-info":[{"award-number":["AI0822714"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["GM104938"],"award-info":[{"award-number":["GM104938"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.rdc.2020.05.004","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T18:12:07Z","timestamp":1593799927000},"page":"513-532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Sj\u00f6gren Syndrome and Cancer"],"prefix":"10.1016","volume":"46","author":[{"given":"Ann","family":"Igoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sali","family":"Merjanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Hal","family":"Scofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2020.05.004_bib1","unstructured":"Sjogren, H. A New Conception of Keratoconjunctivitis Sicca (Keratitis Fili- formis in Hypofunction of the Lacrymal Glands). (Translated by J. Bruce Hamilton.) Australasian Medical Publishing Company, Ltd. Glebe, N.S.W., Australia, I943."},{"key":"10.1016\/j.rdc.2020.05.004_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1756-185X.2012.01717.x","article-title":"A\u00a0study of the prevalence of sicca symptoms and secondary Sj\u00f6gren\u2019s syndrome in patients with rheumatoid arthritis , and its association to disease activity and treatment profile","volume":"15","author":"Haga","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.rdc.2020.05.004_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02987866","article-title":"Gallium-67 scintigraphic findings in a patient with breast lymphoma complicated with Sj\u00f6gren syndrome","volume":"14","author":"Yoshimura","year":"2000","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.rdc.2020.05.004_bib4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/rheumatology\/kep404","article-title":"Incidence of malignancy in primary Sj\u00f6gren\u2019s syndrome in a Chinese cohort","volume":"49","author":"Zhang","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2020.05.004_bib5","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/rheumatology\/kei281","article-title":"Incidence of cancer in a cohort of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"45","author":"Lazarus","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2020.05.004_bib6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2013-203305","article-title":"Primary Sj\u00f6gren\u2019s syndrome and malignancy risk: A systematic review and meta-analysis","volume":"73","author":"Liang","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2020.05.004_bib7","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.20176","article-title":"Mortality and Causes of Death in Primary Sj\u00f6gren\u2019s Syndrome: A Prospective Cohort Study","volume":"50","author":"Theander","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2020.05.004_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.autrev.2009.07.002","article-title":"Secondary tumours in Sj\u00f6gren\u2019s syndrome","volume":"9","author":"Kov\u00e1cs","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2020.05.004_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00296-014-3051-x","article-title":"Identification of lymphoma predictors in patients with primary Sj\u00f6gren\u2019s syndrome: A systematic literature review and meta-analysis","volume":"35","author":"Nishishinya","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.rdc.2020.05.004_bib10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/0961203319857132","article-title":"Prognostic markers of lymphoma development in primary Sj\u00f6gren syndrome","volume":"28","author":"Retamozo","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2020.05.004_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/03009742.2018.1523456","article-title":"Comparison of patients with and without pre-existing lymphoma at diagnosis of primary Sj\u00f6gren\u2019s syndrome","volume":"48","author":"Vasaitis","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.rdc.2020.05.004_bib12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/art.39518","article-title":"Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sj\u00f6gren\u2019s Syndrome","volume":"68","author":"Nocturne","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rdc.2020.05.004_bib13","first-page":"69","article-title":"Development of lymphoma in patients with primary Sj\u00f6gren syndromes","volume":"14","author":"Schenone","year":"2019","journal-title":"Int J Clin Rheumtol"},{"key":"10.1016\/j.rdc.2020.05.004_bib14","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1182\/blood-2008-07-077982","article-title":"Classification of lymphoid neoplasms: The microscope as a tool for disease discovery","volume":"112","author":"Jaffe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2020.05.004_bib15","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.rdc.2020.05.004_bib16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","article-title":"Hematologic manifestations and predictors of lymphoma development in primary sj\u00f6gren syndrome: Clinical and pathophysiologic aspects","volume":"88","author":"Baimpa","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2020.05.004_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e31824125e4","article-title":"Prognosis and outcome of non-hodgkin lymphoma in primary sj\u00f6gren syndrome","volume":"91","author":"Voulgarelis","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2020.05.004_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.semarthrit.2013.03.001","article-title":"Clinical features distinguishing lymphoma development in primary Sj\u00f6gren\u2019s syndrome-A retrospective cohort study","volume":"43","author":"Risselada","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2020.05.004_bib19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.autrev.2018.02.003","article-title":"Cytokine markers of B lymphocytes in minor salivary gland infiltrates in Sj\u00f6gren\u2019s syndrome","volume":"17","author":"Navarro-Mendoza","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2020.05.004_bib20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13045-017-0464-5","article-title":"Characterization and risk estimate of cancer in patients with primary Sj\u00f6gren syndrome","volume":"10","author":"Brito-Zer\u00f3n","year":"2017","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.rdc.2020.05.004_bib21","first-page":"S150","article-title":"The evaluation of disease activity in Sj\u00f6gren\u2019s syndrome based on the degree of MALT involvement: Glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study","volume":"36","author":"De Vita","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2020.05.004_bib22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ijc.24287","article-title":"Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies","volume":"125","author":"Anderson","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.rdc.2020.05.004_bib23","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: A pooled analysis within the InterLymph Consortium","volume":"111","author":"Ekstr\u00f6m Smedby","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2020.05.004_bib24","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1158\/1055-9965.EPI-16-0212","article-title":"Comprehensive evaluation of medical conditions associated with risk of non-Hodgkin lymphoma using medicare claims (\u2018MedWAS\u2019)","volume":"25","author":"Engels","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.rdc.2020.05.004_bib25","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","article-title":"Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue","volume":"101","author":"Zucca","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2020.05.004_bib26","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","article-title":"Malignant lymphoma in primary Sjogren\u2019s syndrome: A multicenter, retrospective, clinical study by the European concerted action on Sjogren\u2019s syndrome","volume":"42","author":"Voulgarelis","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2020.05.004_bib27","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/acr.21887","article-title":"Risk of non-Hodgkin\u2019s lymphoma in primary Sj\u00f6gren\u2019s syndrome: A population-based study","volume":"65","author":"Johnsen","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rdc.2020.05.004_bib28","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/art.1780390508","article-title":"Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in Primary Sj\u00f6gren\u2019s Syndrome","volume":"39","author":"Tzioufas","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2020.05.004_bib29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/rheumatology\/38.3.245","article-title":"Primary Sjogren\u2019s syndrome in the North East of England: A long-term follow-up study","volume":"38","author":"Davidson","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2020.05.004_bib30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/ard.60.5.467","article-title":"A\u00a0longitudinal cohort study of Finnish patients with primary Sj\u00f6gren\u2019s syndrome: Clinical, immunological, and epidemiological aspects","volume":"60","author":"Pertovaara","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2020.05.004_bib31","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/ard.2004.029066","article-title":"Development of additional autoimmune diseases in a population of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"64","author":"Lazarus","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2020.05.004_bib32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.semarthrit.2011.04.006","article-title":"Risk, Predictors, and Clinical Characteristics of Lymphoma Development in Primary Sj\u00f6gren\u2019s Syndrome","volume":"41","author":"Solans-Laqu\u00e9","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2020.05.004_bib33","first-page":"S102","article-title":"How immunological profile drives clinical phenotype of primary Sj\u00f6gren\u2019s syndrome at diagnosis: Analysis of 10,500 patients (Sj\u00f6gren Big Data Project)","volume":"36","author":"Brito-Zer\u00f3n","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2020.05.004_bib34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1191\/096120398678920019","article-title":"Young onset of primary Sjogren\u2019s syndrome: Clinical and immunological characteristics","volume":"7","author":"Ramos-Casals","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2020.05.004_bib35","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sj\u00f6gren\u2019s syndrome disease activity index: Development of a consensus systemic disease activity index for primary Sj\u00f6gren\u2019s syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2020.05.004_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.22141\/2663-3272.2.3.2019.186472","article-title":"Prognostic markers of lymphoma in primary Sjogren\u2019s syndrome","volume":"2","author":"Golovach","year":"2019","journal-title":"Pract Oncol"},{"key":"10.1016\/j.rdc.2020.05.004_bib37","first-page":"2376","article-title":"Differential risk of non-Hodgkin\u2019s lymphoma in Italian patients with primary Sj\u00f6gren\u2019s syndrome","volume":"24","author":"Valesini","year":"1997","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2020.05.004_bib38","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sj\u00f6gren\u2019s syndrome","volume":"46","author":"Ioannidis","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2020.05.004_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0000000000003766","article-title":"Predicting the risk for lymphoma development in Sjogren syndrome","volume":"95","author":"Fragkioudaki","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2020.05.004_bib40","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","article-title":"Clinical evolution, and morbidity and mortality of primary Sjogren\u2019s syndrome","volume":"29","author":"Skopouli","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2020.05.004_bib41","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sj\u00f6gren\u2019s syndrome: A cohort study on cancer incidence and lymphoma predictors","volume":"65","author":"Theander","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2020.05.004_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7861\/clinmedicine.14-2-157","article-title":"A\u00a0retrospective study of long-term outcomes in 152 patients with primary Sj\u00f6gren\u2019s syndrome: 25-Year experience","volume":"14","author":"Abrol","year":"2014","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.rdc.2020.05.004_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaut.2013.10.002","article-title":"Biomarkers of lymphoma in Sj\u00f6gren\u2019s syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: Results of a multicenter study","volume":"51","author":"Quartuccio","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.rdc.2020.05.004_bib44","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/rheumatology\/kem079","article-title":"Predicting adverse outcomes in primary Sj\u00f6gren\u2019s syndrome: Identification of prognostic factors","volume":"46","author":"Brito-Zer\u00f3n","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2020.05.004_bib45","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.autrev.2015.07.002","article-title":"Anti-SSA\/SSB-negative Sj\u00f6gren\u2019s syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution","volume":"14","author":"Quartuccio","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2020.05.004_bib46","first-page":"S198","article-title":"Phenotyping Sj\u00f6gren\u2019s syndrome: Towards a personalised management of the disease","volume":"36","author":"Brito-Zer\u00f3n","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2020.05.004_bib47","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00296-020-04529-0","article-title":"Serum immunoglobulin G4 in Sj\u00f6gren\u2019s syndrome: a pilot study","volume":"40","author":"Ma\u015bli\u0144ska","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.rdc.2020.05.004_bib48","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/annrheumdis-2014-206418","article-title":"Systemic activity and mortality in primary Sj\u00f6gren syndrome: Predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients","volume":"75","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2020.05.004_bib49","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/annonc\/mdu365","article-title":"Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study","volume":"25","author":"Fallah","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.rdc.2020.05.004_bib50","doi-asserted-by":"crossref","first-page":"80461","DOI":"10.18632\/oncotarget.19057","article-title":"Hydroxychloroquine and risk of cancer in patients with primary Sj\u00f6gren syndrome: Propensity score matched landmark analysis","volume":"8","author":"Fang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.rdc.2020.05.004_bib51","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.diii.2014.08.004","article-title":"Cerebral tumor or pseudotumor?","volume":"95","author":"Leclercq","year":"2014","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.rdc.2020.05.004_bib52","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jns.2014.01.027","article-title":"Pseudotumoral brain lesion as the presenting feature of primary Sj\u00f6gren\u2019s syndrome","volume":"339","author":"Sassi","year":"2014","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.rdc.2020.05.004_bib53","first-page":"253","article-title":"Cerebelous Pseudotumor due to a Localized Vasculitis as First Presentation of Sj\u00f6gren Syndrome","volume":"9","author":"Telenti-Rodr\u00edguez","year":"2018","journal-title":"J\u00a0Neurol Neurosci"},{"key":"10.1016\/j.rdc.2020.05.004_bib54","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3174\/ajnr.A1204","article-title":"Primary Sj\u00f6gren syndrome with tumefactive central nervous system involvement","volume":"29","author":"Sanahuja","year":"2008","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.rdc.2020.05.004_bib55","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.semarthrit.2010.06.005","article-title":"Atypical Neurologic Complications in Patients with Primary Sj\u00f6gren\u2019s Syndrome: Report of 4 Cases","volume":"40","author":"Michel","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2020.05.004_bib56","doi-asserted-by":"crossref","first-page":"e9329","DOI":"10.1097\/MD.0000000000009329","article-title":"Primary spinal mucosa-associated lymphoid tissue lymphoma: A case report","volume":"97","author":"Dong","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2020.05.004_bib57","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1440-1789.2001.00392.x","article-title":"Primary extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type in the CNS","volume":"21","author":"Itoh","year":"2001","journal-title":"Neuropathology"},{"key":"10.1016\/j.rdc.2020.05.004_bib58","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/hed.10311","article-title":"Management of neurotropic low-grade B-cell lymphoma: Report of two cases","volume":"25","author":"Garcia-Serra","year":"2003","journal-title":"Head Neck"},{"key":"10.1016\/j.rdc.2020.05.004_bib59","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00000478-199701000-00009","article-title":"Primary low-grade B-cell lymphoma of the dura: A mucosa associated lymphoid tissue-type lymphoma","volume":"21","author":"Kumar","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.rdc.2020.05.004_bib60","first-page":"311","article-title":"Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) arising in dura","volume":"17","author":"Kambham","year":"1998","journal-title":"Clin Neuropathol"},{"key":"10.1016\/j.rdc.2020.05.004_bib61","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-227581","article-title":"Breast MALT lymphoma and AL amyloidosis complicating Sj\u00f6gren\u2019s syndrome","volume":"12","author":"Belfeki","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.rdc.2020.05.004_bib62","first-page":"1","article-title":"Primary MALT Lymphoma of the Breast Treated with Definitive Radiation","volume":"2016","author":"Hissourou","year":"2016","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.rdc.2020.05.004_bib63","first-page":"632","article-title":"Cutaneous manifestation of primary Sj\u00f6gren\u2019s syndrome are underestimated","volume":"22","author":"Roguedas","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2020.05.004_bib64","article-title":"164 Sjogren\u2019s syndrome and localisedlocalized nodular cutaneous amyloidosis: new insights into the link between the two","author":"Walsh","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.rdc.2020.05.004_bib65","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/ard.49.8.646","article-title":"Hodgkin\u2019s disease occurring in primary Sjogren\u2019s syndrome","volume":"49","author":"Mart\u00edn-Santos","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2020.05.004_bib66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/014107688808100121","article-title":"Sj\u00f6gren\u2019s syndrome and pleomorphic T-cell lymphoma presenting with skin involvement","volume":"81","author":"Rustin","year":"1988","journal-title":"J\u00a0R Soc Med"},{"key":"10.1016\/j.rdc.2020.05.004_bib67","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/ajcp\/92.3.357","article-title":"Sjogren\u2019s syndrome with specific cutaneous manifestations and multifocal clonal T-cell populations progressing to a cutaneous pleomorphic T-cell lymphoma","volume":"92","author":"Van Der Valk","year":"1989","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.rdc.2020.05.004_bib68","first-page":"888","article-title":"Angioimmunoblastic T-cell lymphoma: A relatively common type of T-cell lymphoma in Sj\u00f6gren\u2019s syndrome","volume":"23","author":"Saito","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2020.05.004_bib69","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.semarthrit.2005.07.001","article-title":"Characterization of T-Cell Large Granular Lymphocyte Leukemia Associated with Sjogren\u2019s Syndrome-An Important but Underrecognized Association","volume":"35","author":"Friedman","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2020.05.004_bib70","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4103\/njms.NJMS_50_15","article-title":"Refractory Sj\u00f6gren\u2019s Syndrome: Is parotidectomy justified?","volume":"10","author":"Singh","year":"2019","journal-title":"Natl J Maxillofac Surg"},{"key":"10.1016\/j.rdc.2020.05.004_bib71","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1590\/S1808-86942011000500017","article-title":"Primary Non-Hodgkins lymphoma of the parotid gland","volume":"77","author":"Dispenza","year":"2011","journal-title":"Braz J Otorhinolaryngol"},{"key":"10.1016\/j.rdc.2020.05.004_bib72","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00296-011-1851-9","article-title":"Parotid gland non-Hodgkin lymphoma in primary Sj\u00f6gren syndrome","volume":"32","author":"Zenone","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.rdc.2020.05.004_bib73","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/art.39534","article-title":"Brief Report: Monoclonal Gammopathy and Risk of Lymphoma and Multiple Myeloma in Patients with Primary Sj\u00f6gren\u2019s Syndrome","volume":"68","author":"Tomi","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rdc.2020.05.004_bib74","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/annrheumdis-2019-216287","article-title":"Increased risk of multiple myeloma in primary Sj\u00f6gren\u2019s syndrome is limited to individuals with Ro\/SSA and La\/SSB autoantibodies","volume":"79","author":"Mofors","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2020.05.004_bib75","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00296-019-04433-2","article-title":"Incidence of cancer in a cohort of patients with primary Sj\u00f6gren syndrome in Argentina","volume":"39","author":"Brom","year":"2019","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.rdc.2020.05.004_bib76","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s10067-018-4064-8","article-title":"Monoclonal gammopathy in rheumatic diseases","volume":"37","author":"Yang","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2020.05.004_bib77","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1183\/16000617.0011-2016","article-title":"Pulmonary manifestations of Sj\u00f6gren\u2019s syndrome","volume":"25","author":"Flament","year":"2016","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.rdc.2020.05.004_bib78","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/1759-7714.12216","article-title":"The Prevalence and clinical characteristics of primary Sjogren\u2019s syndrome patients with lung cancer: An analysis of ten cases in China and literature review","volume":"6","author":"Xu","year":"2015","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.rdc.2020.05.004_bib79","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3899\/jrheum.090507","article-title":"Pulmonary manifestations in Sj\u00f6gren\u2019s syndrome: Correlation analysis between chest computed tomographic findings and clinical subsets with poor prognosis in 80 patients","volume":"37","author":"Watanabe","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2020.05.004_bib80","first-page":"409","article-title":"A\u00a0case of primary Sj\u00f6gren\u2019s syndrome complicated with lung adenocarcinoma","volume":"45","author":"Uji","year":"2007","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"10.1016\/j.rdc.2020.05.004_bib81","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1440-1843.1999.00171.x","article-title":"Lung adenocarcinoma in lymphocytic interstitial pneumonitis associated with primary Sj\u00f6gren\u2019s syndrome","volume":"4","author":"Takabatake","year":"1999","journal-title":"Respirology"},{"key":"10.1016\/j.rdc.2020.05.004_bib82","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.athoracsur.2012.06.051","article-title":"A\u00a0rare association of pulmonary carcinoid, lymphoma, and Sj\u00f6gren syndrome","volume":"95","author":"Taylor","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.rdc.2020.05.004_bib83","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0272-5231(21)00171-4","article-title":"The lymphocytic infiltrative lung diseases","volume":"3","author":"Vath","year":"1982","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.rdc.2020.05.004_bib84","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: Evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.rdc.2020.05.004_bib85","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/jclinpath-2015-203342","article-title":"Nodular pulmonary light chain deposition disease: An entity associated with Sj\u00f6gren syndrome or marginal zone lymphoma","volume":"69","author":"Arrossi","year":"2016","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.rdc.2020.05.004_bib86","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/S0002-9440(10)65520-4","article-title":"Somatic mutations of the L12a gene in V-\u03ba1 light chain deposition disease: Potential effects on aberrant protein conformation and deposition","volume":"155","author":"Vidal","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.rdc.2020.05.004_bib87","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.pas.0000213358.18380.d2","article-title":"Pulmonary light chain deposition disease: Report of five cases and review of the literature","volume":"31","author":"Bhargava","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.rdc.2020.05.004_bib88","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1164\/rccm.200510-1620CR","article-title":"Pulmonary Cystic Disorder Related to Light Chain Deposition Disease","volume":"173","author":"Colombat","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rdc.2020.05.004_bib89","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1164\/rccm.201301-0071LE","article-title":"Mass Spectrometry\u2013based Proteomic Analysis: A Good Diagnostic Tool for Cystic Lung Light Chain Deposition Disease","volume":"188","author":"Colombat","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rdc.2020.05.004_bib90","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/RLU.0b013e3181e4dd44","article-title":"Pulmonary light and heavy chain deposition disease: A pitfall for lung cancer evaluation with F-18 FDG PET\/CT","volume":"35","author":"Makis","year":"2010","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.rdc.2020.05.004_bib91","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1440-1843.2009.01560.x","article-title":"Pulmonary manifestations of light chain deposition disease","volume":"14","author":"Rho","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.rdc.2020.05.004_bib92","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1513\/AnnalsATS.201404-137OC","article-title":"Lung Transplantation for Advanced Cystic Lung Disease Due to Nonamyloid Kappa Light Chain Deposits","volume":"11","author":"Hirschi","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.rdc.2020.05.004_bib94","series-title":"AFIP atlas of tumor pathology: tumors of the mediastinum","author":"Shimosato","year":"2010"},{"key":"10.1016\/j.rdc.2020.05.004_bib95","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13000-015-0332-y","article-title":"Thymic lymphoid hyperplasia with multilocular thymic cysts diagnosed before the Sj\u00f6gren syndrome diagnosis","volume":"10","author":"Minato","year":"2015","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.rdc.2020.05.004_bib96","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00000478-199104000-00008","article-title":"Multilocular thymic cyst: an acquired reactive process. Study of 18 cases","volume":"15","author":"Suster","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.rdc.2020.05.004_bib97","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.humpath.2005.05.004","article-title":"Multilocular thymic cyst associated with follicular hyperplasia: Clinicopathologic study of 4 resected cases","volume":"36","author":"Izumi","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.rdc.2020.05.004_bib98","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11604-008-0298-8","article-title":"Pulmonary and thymic lymphoid hyperplasia in primary Sj\u00f6gren\u2019s syndrome","volume":"27","author":"Kobayashi","year":"2009","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.rdc.2020.05.004_bib99","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0003-4975(00)02706-5","article-title":"Multilocular thymic cyst associated with Sj\u00f6gren\u2019s syndrome","volume":"72","author":"Kondo","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.rdc.2020.05.004_bib100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/rheumatology\/key221","article-title":"Multilocular thymic cyst in a patient with Sj\u00f6gren syndrome","volume":"58","author":"Gorospe","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2020.05.004_bib101","first-page":"89","article-title":"Multilocular thymic cyst","volume":"16","author":"Goldman","year":"1992","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.rdc.2020.05.004_bib102","first-page":"946","article-title":"The influence of immunosuppressants on the non-melanoma skin cancer among patients with systemic lupus erythematosus and primary Sj\u00f6gren\u2019s syndrome: a nationwide retrospective case-control study in Taiwan","volume":"37","author":"Tseng","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2020.05.004_bib103","doi-asserted-by":"crossref","first-page":"347","DOI":"10.12659\/AJCR.902828","article-title":"Rapidly developed multiple face and neck skin cancers in a patient with Sj\u00f6gren\u2019s syndrome: A case report","volume":"18","author":"Teh","year":"2017","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.rdc.2020.05.004_bib104","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ygyno.2012.07.100","article-title":"Effect of autoimmune diseases on risk and survival in female cancers","volume":"127","author":"Hemminki","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.rdc.2020.05.004_bib105","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/ijc.31148","article-title":"Autoimmune diseases and breast cancer risk by tumor hormone-receptor status among elderly women","volume":"142","author":"Schairer","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.rdc.2020.05.004_bib106","article-title":"Comorbidities (excluding lymphoma) in Sj\u00f6gren\u2019s syndrome","author":"Pego-Reigosa","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2020.05.004_bib107","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2174\/1573397113666170103152537","article-title":"Coexistance of Amyloidosis and Primary Sj\u00f6gren\u2019s Syndrome: An Overview","volume":"14","author":"Hernandez-Molina","year":"2018","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.rdc.2020.05.004_bib108","first-page":"31","article-title":"Amyloid tumor of the breast","volume":"5","author":"Mori","year":"2019","journal-title":"Surg Case Reports"},{"key":"10.1016\/j.rdc.2020.05.004_bib109","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4048\/jbc.2011.14.4.337","article-title":"Clinically positive axillary lymphadenopathy may lead to false diagnosis of overstaged breast cancer in patients with sj\u00f6gren\u2019s syndrome: A case report","volume":"14","author":"Cipe","year":"2011","journal-title":"J\u00a0Breast Cancer"},{"key":"10.1016\/j.rdc.2020.05.004_bib110","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.amjoto.2008.04.002","article-title":"Sjogren\u2019s syndrome masquerading as nasopharyngeal carcinoma","volume":"30","author":"Lal","year":"2009","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.rdc.2020.05.004_bib111","first-page":"912","article-title":"Unusual cancer in primary Sj\u00f6gren syndrome","volume":"60","author":"Lai","year":"2014","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.rdc.2020.05.004_bib112","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1044579X0200086X","article-title":"Epstein-Barr virus in the pathogenesis of NPC","volume":"12","author":"Raab-Traub","year":"2002","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.rdc.2020.05.004_bib113","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/BOR.0b013e32836200d2","article-title":"Autoimmunity and infection in Sj\u00f6gren\u2019s syndrome","volume":"25","author":"Igoe","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.rdc.2020.05.004_bib114","doi-asserted-by":"crossref","first-page":"e11014","DOI":"10.1097\/MD.0000000000011014","article-title":"Primary Sjogren syndrome diagnosed simultaneously with localized amyloidosis of the lacrimal gland","volume":"97","author":"Kweon","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rdc.2020.05.004_bib115","first-page":"43","article-title":"A\u00a0case of Sj\u00f6gren\u2019s syndrome with an eyelid tumor, a so-termed pseudolymphoma of the lacrimal gland","volume":"36","author":"Takeshita","year":"1996","journal-title":"Ryumachi"},{"key":"10.1016\/j.rdc.2020.05.004_bib116","first-page":"302","article-title":"Comparison of human papillomavirus testing and cervical cytology with colposcopic examination and biopsy in cervical cancer screening in a cohort of patients with Sjogren\u2019s syndrome","volume":"28","author":"Cirpan","year":"2007","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.rdc.2020.05.004_bib117","doi-asserted-by":"crossref","first-page":"8688","DOI":"10.11604\/pamj.2015.20.420.6212","article-title":"Association rare: Syndrome de Sj\u00f6gren et liposarcome de la parotide","volume":"20","author":"Madiha","year":"2015","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.rdc.2020.05.004_bib118","series-title":"Kelley and Firestein\u2019s Textbook of Rheumatology (tenth edition)","first-page":"2062","article-title":"Musculosketal syndromes in Malignancy","author":"Vaseer","year":"2017"},{"key":"10.1016\/j.rdc.2020.05.004_bib119","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.1780220816","article-title":"Immunoblastic sarcoma with features of sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus in a patient with immunoblastic lymphadenopathy","volume":"22","author":"Pierce","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2020.05.004_bib120","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrclinonc.2016.58","article-title":"Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination","volume":"13","author":"Boutros","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.rdc.2020.05.004_bib121","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1200\/JCO.2015.60.8448","article-title":"Immune-related adverse events, need for systemic immunosuppression, and effects on survival and time to treatment failure in patients with melanoma treated with ipilimumab at memorial sloan kettering cancer center","volume":"33","author":"Horvat","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.rdc.2020.05.004_bib122","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1200\/JCO.2015.66.1389","article-title":"Safety profile of nivolumab monotherapy: A pooled analysis of patients with advanced melanoma","volume":"35","author":"Weber","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.rdc.2020.05.004_bib123","first-page":"245","article-title":"Occurrence of Sj\u00f6gren syndrome in a long-term survivor patient with metastatic colon carcinoma treated with GOLFIG regimen","volume":"24","author":"Tenti","year":"2012","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.rdc.2020.05.004_bib124","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","article-title":"Increased risk of lymphoma in sicca syndrome","volume":"89","author":"Kassan","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2020.05.004_bib125","first-page":"201","article-title":"Elevated incidence of hematologic malignancies in patients with Sjogren\u2019s syndrome compared with patients with rheumatoid arthritis (Finland)","volume":"8","author":"Kauppi","year":"1997","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.rdc.2020.05.004_bib126","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/annrheumdis-2011-200402","article-title":"Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sj\u00f6gren\u2019s syndrome in Taiwan","volume":"71","author":"Weng","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2020.05.004_bib127","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J","article-title":"Risk of malignancy among patients with rheumatic conditions","volume":"502","author":"Thomas","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.rdc.2020.05.004_bib128","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/cncr.25524","article-title":"Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans","volume":"117","author":"Landgren","year":"2011","journal-title":"Cancer"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X20300569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X20300569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:18:18Z","timestamp":1760181498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X20300569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":127,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0889857X20300569"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2020.05.004","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sj\u00f6gren Syndrome and Cancer","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2020.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}